San Mateo, CA, United States of America

Tony Liang

This inventor holds 10 USPTO granted patents and 5 published patent applications. Top assignees: Cytomx Therapeutics, Inc., Macrogenics, Inc., Ptm Therapeutics, Inc.. Active years: 2008-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tony Liang. Retrieved from https://idiyas.com/inventor/tony-liang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 30.0

Average Co-Inventor Count = 2.9

ph-index = 6

Forward Citations = 94(Granted Patents)


Company Filing History:


Years Active: 2008-2024

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Inventor Tony Liang - Revolutionizing Technology in San Mateo

Introduction: Tony Liang is a visionary inventor based in San Mateo, California, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Tony Liang holds several patents in the areas of artificial intelligence, machine learning, and robotics, showcasing his commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Tony Liang has worked with top tech companies in Silicon Valley, leading research and development teams to create cutting-edge solutions that have transformed industries.

Collaborations: Throughout his career, Tony Liang has collaborated with renowned scientists, engineers, and researchers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Tony Liang's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…